Hutchison China MediTech Ltd ADR Stock
There is an upward development for Hutchison China MediTech Ltd ADR compared to yesterday, with an increase of €0.25 (2.670%).
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 16 € shows a very positive potential of 66.67% compared to the current price of 9.6 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 2.670% | 0.524% | 0.000% | -35.570% | -11.927% | -24.409% | -73.184% |
| China Traditional Chinese Medicine Co Ltd | 0.000% | 0.000% | 0.000% | -10.569% | 0.917% | -44.162% | -56.000% |
| China Resources Pharmaceutical Group Ltd | 0.000% | 0.962% | 8.025% | -10.256% | 10.294% | -21.642% | 19.863% |
| Repligen Corp. | 2.370% | 5.620% | 4.583% | 24.380% | -9.265% | -18.077% | -39.114% |
Comments
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $20.00 to $17.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (HCM) had its price target lowered by Bank of America Corporation from $21.00 to $20.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat